Yes — Steadyway. It tracks the weekly injection, the 0.75 to 4.5 mg ladder, side effects and supply, and it is unusually careful about the one thing Trulicity punishes: the fortnight a pen survives outside the fridge.
| Doses | 0.75, 1.5, 3 and 4.5 mg |
|---|---|
| Taken as | Weekly injection, dulaglutide |
| Licensed for | Type 2 diabetes (UK, EU, US) |
| Out of the fridge | 14 days once in use |
| Missed a dose | Take it if there are at least three days until your next dose. Fewer than three, skip it and take the next one as planned. |
Fourteen days is the shortest window of the lot
Half of Mounjaro's thirty, a third of Wegovy's forty-two. That is the number people get wrong, because it is the one nobody expects to be different — a pen packed for a holiday on the assumptions that work for somebody else's Wegovy will quietly expire while looking completely normal.
The app counts from the day you say the pen came out and nudges you before the window closes.
Where the last one went
Six rotation sites, each showing when it last came round, so the picker suggests the one that has rested longest. A dose taken two days late is logged as late rather than quietly as missed, which matters when the record is going to a diabetes review.
You do not have to use the weight half
Most of Steadyway is built for people losing weight, and on Trulicity most people are not. Nothing in the app requires a goal weight or a target — the dose schedule, the site rotation, the side-effect log and the supply count all stand on their own, and the trend view works fine as a record of what happened rather than a march toward a number.
Something to take to your review
A two-page PDF: trend, doses, side effects, notes. It exists so the appointment starts from a record rather than from what you can remember about the last three months.
